Your Web News in One Place

Help Webnuz

Referal links:

Sign up for GreenGeeks web hosting
April 16, 2020 05:05 pm

The search for COVID-19 treatments shows how messy science can be

India Goes Into 21 Day Lockdown Due To Coronavirus COVID 19

Photo by Samir Jana/Hindustan Times via Getty Images

There’s yet another new study out this week on hydroxychloroquine, the anti-malaria drug championed by President Trump (without evidence) as a cure for COVID-19. Bottom line: the hospitalized patients who took it didn’t seem to be any better off than patients who didn’t take the drug. Some patients had to stop taking the drug because of cardiac side effects.

The report isn’t published yet, and hasn’t gone through the standard review process, but doctors are starting to sort through its findings. It’s not a good sign for the drug. But this single study is not a killer blow, either.

That’s because a lone study or single clinical trial rarely offers incontrovertible evidence to disprove or bolster a claim — especially if, like this one,...

Continue reading…

Original Link:

Share this article:    Share on Facebook
View Full Article

The Verge

The Verge is an ambitious multimedia effort founded in 2011

More About this Source Visit The Verge